Indegene LtdHealthcare Research- Analytics and TechnologyINE065X01017Consolidated₹597.50+6.30 (+1.07%)Jun-26
Valuation
Market Cap₹14.46K Cr
TTM PE35.91x
Forward PE36.15x
PEG-299.25
Book Value₹130.26
P/B4.61x
TTM EPS₹16.71
Fwd EPS₹16.60
TTM Revenue₹3.81K Cr
TTM PAT₹400.90 Cr
TTM EBITDA₹637.90 Cr
TTM EBIT₹489.00 Cr
Last Qtr PAT₹116.20 Cr
Last Qtr EBITDA₹174.20 Cr
Last Qtr EBIT₹130.10 Cr
Profitability
ROE12.77%
ROCE16.68%
TTM NPM10.51%
TTM EBITDA %16.73%
Curr OPM10.64%
Last OPM7.86%
Curr NPM—
Last NPM—
Curr EPS₹4.84
Last EPS₹3.32
Balance sheet
Equity₹48.10 Cr
Reserve₹3.09K Cr
Total Debt₹144.40 Cr
D/E0.05x
Interest %5.51%
Curr Interest₹6.40 Cr
Price / range
Close₹600.10
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.41%
1W+3.36%
1M+5.37%
3M+15.48%
6M+32.02%
1Y+2.41%
2Y-8.81%
3Y—
5Y—
Diwali+15.50%
Sector peers — Healthcare Research- Analytics and Technology
| Company | Close | Mkt Cap | TTM P/E | ROE |
|---|
| SYNGENE | 369.05 | ₹14.90K Cr | 67.10 | 4.57% |
| INDGN | 600.10 | ₹14.46K Cr | 35.91 | 12.77% |
| SUVEN | 341.55 | ₹9.65K Cr | -22.94 | -59.59% |
| VIMTALABS | 603.10 | ₹2.69K Cr | 22.62 | 13.43% |
| BI | 109.14 | ₹256.97 Cr | -22.32 | — |
| TAKE | 15.96 | ₹236.10 Cr | 40.92 | 41.35% |
| JSTL | 81.25 | ₹161.84 Cr | -49.85 | — |
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits